Inventor
Alan D. D'Andrea
Inventor
Winchester, MA, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides21%
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
A61KPreparations for medical, dental or toiletry purposes15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%
C07DHeterocyclic compounds8%
A01KAnimal husbandry6%
C07CAcyclic or carbocyclic compounds4%
C12NMicroorganisms or enzymes4%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
10,738,310Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor202010,653,676Small molecule inhibitors of USP1 deubiquitinating enzyme activity202010,526,402Anti-TGF-beta antibody for the treatment of fanconi anemia202010,450,281Compounds and methods for treating cancer20199,725,425'Compounds and methods for treating cancer'20179,518,032'Small molecule inhibitors of USP1 deubiquitinating enzyme activity'20169,354,224'Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof'20168,597,900'Compositions and methods for the treatment of cancer'20138,541,192'Methods to identify USP1 deubiquitinating enzyme complex inhibitors'20138,541,198'Method for determination and quantification of radiation or genotoxin exposure'20137,910,325'Method for determination and quantification of radiation or genotoxin exposure'20117,858,331'Compositions and methods for the treatment of cancer'20107,754,463'Inhibitors of USP1 Deubiquitinating Enzyme Complex'20107,459,287'Method for determination and quantification of radiation or genotoxin exposure'20086,287,858'DeUBiquitinating enzymes that regulate cell growth'20015,378,808'Recombinant erythropoietin receptor protein'19955,278,065'Recombinant DNA endoding an erythropoietin receptor'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–1995Patents assigned to GENETICS INST (2)· patent assignee history
1994–2020Based in Winchester, MA, US· patent location history
2001–2020Patents assigned to DANA FARBER CANCER INST INC (14)· patent assignee history
2013Patents assigned to D ANDREA ALAN D (3)· patent assignee history
2016–2020Patents assigned to BRIGHAM & WOMENS HOSPITAL INC (2)· patent assignee history
2016Patents assigned to CASE APRIL (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DANA FARBER CANCER INST INC | 14 | 2001–2020 |
| D ANDREA ALAN Dself | 3 | 2013 |
| BRIGHAM & WOMENS HOSPITAL INC | 2 | 2016–2020 |
| GENETICS INST | 2 | 1994–1995 |
| CASE APRIL | 1 | 2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Winchester, Massachusetts, US | 17 | 1994–2020 |